Dealing with type one diabetes is very intimidating, but when it is done with teamwork, it is equally empowering. Attending the ADA Scientific Sessions and witnessing the volume of research being done was a testament to that. The daily selection of presentations covered everything from nutrition and immunology to psychology and epigenetic pathogenesis; hearing such a diverse range of perspectives helped me understand that my future role in the field, as a biomedical engineer, can take all shapes and sizes. I was particularly fascinated at the persistent difficulty researchers have with increasing the success rate of immunotherapy regimens, both before clinical diagnosis and after islet transplants. At times, it seemed that the progress being made was still so limited; however, I would be amiss if that was my final verdict, because the dialogue following every presentation was a melting pot of new ideas for further research that could turn every promising study into a widespread intervention. My generation—the “Next Generation”—will be tasked with making these pivotal innovations. It is my hope that a few years from today, I will reconvene with everyone I met in those five days at a future Scientific Sessions, to present findings of our own, gain that invaluable feedback, and bring forth the long-awaited cure.